Patient Blood Management Market Report 2026

Patient Blood Management Market Overview

• Patient Blood Management market size has reached to $15.94 billion in 2025 • Expected to grow to $22.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.6% • Growth Driver: Growth Of Patient Blood Management Market Driven By Increasing Surgical Procedures • Market Trend: Innovations In Medical Devices Enhance Blood Transfusion Efficiency And Patient Experience • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Patient Blood Management Market?

Patient blood management is a patient-focused, evidence-based, and systematic approach to optimizing the care of patients, who might need a blood transfusion, by optimizing patients’ blood, minimizing surgical blood loss, and harnessing the patient-specific physiological reserve of anemia thereby reducing the need for allogeneic blood transfusions. The patient blood management is segmented by product into instruments, accessories, reagents and kits, and software. The patient blood management kits are used to manage the patient’s blood. It is also segmented by component into plasma, whole blood, and red blood cells that are used for applications such as hospitals, clinics, and others.

What Is The Patient Blood Management Market Growth Forecast?

The patient blood management market size is expected to see strong growth in the next few years. It will grow to $22.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to aging population growth, elective surgery growth, stricter transfusion regulations, value-based healthcare adoption, expansion of pbm in emerging markets. Major trends in the forecast period include preoperative anemia screening protocols, point-of-care hemoglobin testing, standardized transfusion guidelines adoption, multidisciplinary PBM programs in hospitals, increased clinician education on PBM.

Global Patient Blood Management Market Segmentation

1) By Product: Instruments, Accessories, Reagents And Kits, Software 2) By Component: Plasma, Whole Blood, Red Blood Cells 3) By Application: Hospital, Clinic, Other Applications Subsegments: 1) By Instruments: Blood Collection Devices, Blood Processing Devices, Blood Transfusion Devices 2) By Accessories: Blood Bags, Transfer Sets, Filters 3) By Reagents And Kits: Blood Typing Reagents, Coagulation Test Kits, Hemoglobin Test Kits 4) By Software: Blood Management Information Systems, Data Management Software, Inventory Management Software

What Is The Driver Of The Patient Blood Management Market?

The increasing surgical procedures is expected to propel the growth of the patient blood management market going forward. Surgical procedures refer to medical interventions that involve the physical manipulation of tissues or organs to diagnose, treat, or prevent health conditions, often requiring incisions and the use of surgical instruments. This rise is due to the growing prevalence of chronic diseases, advancements in medical technology, improved surgical techniques, and an aging population. Patient blood management enhances surgical outcomes by optimizing blood use, reducing transfusion needs, minimizing complications, and improving results through effective preoperative assessment and anemia management. For instance, in August 2023, according to The Aesthetic Society, a US-based organization of plastic surgery and cosmetic medicine, Americans spent more than $11.8 billion on aesthetic procedures overall, up 2% from 2022. Therefore, the increasing surgical procedures is driving the growth of the patient blood management production market.

Key Players In The Global Patient Blood Management Market

Major companies operating in the patient blood management market are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, KANEKA CORPORATION, Bio-Rad Laboratories Inc, Abbott Laboratories, Grifols, Roche, LIVANOVA PLC, Danaher, Mediware information systems, Kawasumi Laboratories, Haier Biomedical, Diatron MI Zrt., BAG Diagnostics GmbH, Hitachi Ltd., Ortho Clinical Diagnostics, Beckman Coulter Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Sysmex Corporation, Nihon Kohden Corporation, Radiometer Medical ApS, Instrumentation Laboratory, F. Hoffmann-La Roche Ltd, Grifols Diagnostic Solutions Inc., HemoCue AB

Global Patient Blood Management Market Trends and Insights

Major companies operating in the patient blood management market are focusing on innovative products, such as medical devices for blood transfusions, to drive revenues in their market. Medical devices used in blood transfusions are designed to safely and efficiently transfer blood or blood products from donors to recipients. For instance, in May 2024, Becton, Dickinson, and Company, a US-based medical technology company, launched UltraTouch, engineered to streamline the process of obtaining blood samples while minimizing patient discomfort. It utilizes advanced technology to enable quick and efficient venipuncture, ensuring high accuracy in sample collection. Designed with a user-friendly interface and ergonomic features, it is well-suited for healthcare professionals across various environments, including hospitals, clinics, and laboratories. This device is especially advantageous for patients who experience anxiety during blood draws, as its innovative design helps reduce pain and improve the overall experience. Furthermore, it includes safety mechanisms to lower the risk of needle-stick injuries, making it a favored option in contemporary medical practice.

What Are Latest Mergers And Acquisitions In The Patient Blood Management Market?

In December 2024, GVS S.p.A., an Italy-based medical device and filtration company, acquired the Transfusion Medicine business of Haemonetics Corporation. Through this acquisition, GVS aims to strengthen its position in the healthcare filtration sector and expand its global reach by integrating Haemonetics’ proprietary solutions for blood collection, processing, filtration, and transfusion. Haemonetics Corporation is a US-based company specializing in transfusion medicine and blood management solutions.

Regional Outlook

North America was the largest region in the patient blood management market in 2025. Western Europe was the second-largest region in the patient blood management market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Patient Blood Management Market?

The patient blood management market includes revenues earned by instruments, blood processing devices, and centrifuges. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.